Cargando…

Consumer Understanding and Satisfaction Associated With a 3-Tier Prescription Drug Benefit

OBJECTIVES: The purpose of this research was to investigate consumer understanding and satisfaction associated with a 3-tier prescription drug benefit among users of the prescription drug benefit. METHODS: This study involved a self-administered postal questionnaire and the use of prescription drug...

Descripción completa

Detalles Bibliográficos
Autores principales:	Olson, Bridget M., Malone, Daniel C., Zachry, Woodie M., Coons, Stephen Joel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Academy of Managed Care Pharmacy 2005
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437368/ https://www.ncbi.nlm.nih.gov/pubmed/15998165 http://dx.doi.org/10.18553/jmcp.2005.11.6.480

Ejemplares similares

Cost-Effectiveness Analysis of Simvastatin and Lovastatin/Extended-Release Niacin to Achieve LDL and HDL Goal Using NHANES Data
por: Armstrong, Edward P., et al.
Publicado: (2004)

1557. The Real-World Impact of Pre-Exposure Prophylaxis (PrEP) Prescription Uptake and Dispensing Status on HIV Infection Risk in the US
por: Tao, Li, et al.
Publicado: (2023)

Correction to: Systematic Review of the Economic Burden of Overt Hepatic Encephalopathy and Pharmacoeconomic Impact of Rifaximin
por: Neff, Guy, et al.
Publicado: (2018)

Systematic Review of the Economic Burden of Overt Hepatic Encephalopathy and Pharmacoeconomic Impact of Rifaximin
por: Neff, Guy, et al.
Publicado: (2018)

Unraveling the Effects of Tier-Copayment Drug Benefit Designs
por: Curtiss, Frederic R.
Publicado: (2003)

Effects of a 3-Tier Pharmacy Benefit Design on the Prescription Purchasing Behavior of Individuals With Chronic Disease
por: NAIR, KAVITA V., et al.
Publicado: (2020)

Effects of a 3-Tier Pharmacy Benefit Design on the Prescription Purchasing Behavior of Individuals With Chronic Disease
por: Nair, Kavita V., et al.
Publicado: (2003)

Promotion of Prescription Drugs to Consumers and Providers, 2001–2010
por: Kornfield, Rachel, et al.
Publicado: (2013)

3-Tier Drug Benefit Designs Based on Sound Drug Formulary Principles Will Maximize Favorable Outcomes
por: Curtiss, Frederic R.
Publicado: (2004)

Member Satisfaction Related to Self-Reported Cost Share and Difficulty in Obtaining Prescription Drugs in a University Pharmacy Benefit Plan
por: Nau, David P., et al.
Publicado: (2007)

Confusing Inequitable Medicare Prescription Drug Benefit
por: Shearer, Gail E.
Publicado: (2007)

Estimating the Cost of a Medicare Outpatient Prescription Drug Benefit
por: Waldo, Daniel R.
Publicado: (1994)

Genetic and economic benefits of selection based on performance recording and genotyping in lower tiers of multi-tiered sheep breeding schemes
por: Santos, Bruno F. S., et al.
Publicado: (2017)

The Tiered Pharmacy Benefit: Challenges in Today’s Health Care Market
por: Kenney, James T.
Publicado: (2020)

What does the Consumer Price Index for prescription drugs really measure?
por: Cleeton, David L., et al.
Publicado: (1992)

Direct-to-Consumer Promotion of Prescription Drugs on Mobile Devices: Content Analysis
por: Aikin, Kathryn J, et al.
Publicado: (2017)

Role of Tier-0, Tier-1 and Tier-2 Regional Centers in CMS DC04
por: Barrass, T, et al.
Publicado: (2004)

Prescription Drug Benefits: Cost Management Issues for Medicare
por: Fox, Peter D.
Publicado: (2003)

Utilization Effects of Prescription Drug Benefits in an Aging Population
por: Gianfrancesco, Frank D., et al.
Publicado: (1994)

The benefits of more government interference in prescription drug pricing
por: Houser, Ryan S.
Publicado: (2022)

Evaluation of benefits of a three tier data model for WLCG analysis
por: Fuhrmann, Patrick, et al.
Publicado: (2012)

Benefit of a Tiered-Trauma Activation System to Triage Dead-on-Arrival Patients
por: Danner, Omar K, et al.
Publicado: (2012)

Direct to consumer advertising of prescription drugs on internet: A Boon or a Curse
por: Khosla, Pratibha, et al.
Publicado: (2011)

Widening Consumer Access to Medicines: A Comparison of Prescription to Non-Prescription Medicine Switch in Australia and New Zealand
por: Gauld, Natalie J., et al.
Publicado: (2015)

Example of shared ATLAS Tier2 and Tier3 facilities
por: Gonzalez de la Hoz, S, et al.
Publicado: (2012)

Twelve Years' Experience with Direct-to-Consumer Advertising of Prescription Drugs in Canada: A Cautionary Tale
por: Mintzes, Barbara, et al.
Publicado: (2009)

Association of Direct-to-Consumer Advertising of Prescription Drugs With Consumer Health-Related Intentions and Beliefs Among Individuals at Risk of Cardiovascular Disease
por: Eisenberg, Matthew D., et al.
Publicado: (2022)

Social Media Analysis to Understand the Expected Benefits by Plant-Based Meat Alternatives Consumers
por: Moreira, Mirian Natali Blézins, et al.
Publicado: (2021)

Predicting anatomic therapeutic chemical classification codes using tiered learning
por: Olson, Thomas, et al.
Publicado: (2017)

The devil in the tiers
por: Feldman, Robin
Publicado: (2021)

A tier-upon-tier march towards the impact factor
por: Martelletti, Paolo
Publicado: (2008)

Pharmacists’ Experiences, Perceptions, and Knowledge of Direct-to-Consumer Prescription Coupons
por: Gernant, Stephanie A., et al.
Publicado: (2020)

LCG Service Challenge 3 at the Spanish Tier-1 and Tier-2 sites
por: Hernández, Jose M, et al.
Publicado: (2006)

Direct-to-consumer advertising of prescription medications: what the Canadian medical trainee needs to know
por: Elfassy, Michael D., et al.
Publicado: (2019)

Do Nostrums Benefit Consumers?
Publicado: (1879)

Direct-to-consumer advertising and expenditures on prescription drugs: a comparison of experiences in the United States and Canada
por: Morgan, Steven G
Publicado: (2007)

Risks and benefits of consuming edible seaweeds
por: Cherry, Paul, et al.
Publicado: (2019)

The impact of Medicare part D prescription drug benefit program on generic drug prescription: A study in long-term care facilities
por: Jung, Changmi, et al.
Publicado: (2019)

CMS DC04 Data Challenge at PIC Tier-1 and CIEMAT Tier-2
por: Hernández, Jose M, et al.
Publicado: (2004)

Illustrative Example of Distributed Analysis in ATLAS Spanish Tier-2 and Tier-3 centers
por: Oliver, E, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_420ml42qmlvg1iapm5t1sopqav